AN ANALYTICAL STUDY TO COMPARE MATERNAL OUTCOMES WHEN MGSO4 THERAPY AFTER LOADING DOSE IS CONTINUED TO 12 HOURS INSTEAD OF 24 HOURS IN SEVERE PREECLAMPSIA AND ECLAMPSIA.
Zenodo (CERN European Organization for Nuclear Research)